Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney
Drugs (2023) Vol. 83, Iss. 15, pp. 1387-1408
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways
Oliwia Koszła, Przemysław Sołek
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 10
Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Geetika Nehra, Bryan Maloney, Rebecca Smith, et al.
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Approved drugs and natural products at clinical stages for treating Alzheimer’s disease
Yajing Ma, Sufang Liu, Qingfeng Zhou, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 699-710
Closed Access | Times Cited: 7
A multifunctional carbon quantum dot overcoming the BBB for modulating amyloid aggregation and scavenging reactive oxygen species
Chaoren Yan, Yixuan Wang, Yandong Ma, et al.
Materials Today Chemistry (2024) Vol. 40, pp. 102222-102222
Closed Access | Times Cited: 6
Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: Current progress in molecular signaling and therapeutics
Sneha Kumari, Rishika Dhapola, Prajjwal Sharma, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102098-102098
Closed Access | Times Cited: 16
Biological and Physical Performance Markers for Early Detection of Cognitive Impairment in Older Adults
Hanna Kerminen, Emanuele Marzetti, Emanuela D’Angelo
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 806-806
Open Access | Times Cited: 5
Emerging role of Metformin in Alzheimer’s disease: A translational view
Juvenal A. Ríos, Juan Carlos Bórquez, Juan A. Godoy, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102439-102439
Closed Access | Times Cited: 5
Intranasal liposomes co-delivery of Aβ-targeted KLVFF and ROS-responsive ceria for synergistic therapy of Alzheimer’s disease
Qiujie Shan, Yue Zhi, Yi Chen, et al.
Chemical Engineering Journal (2024) Vol. 494, pp. 153210-153210
Open Access | Times Cited: 4
Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders
Mi Eun Kim, Jun Sik Lee
Current Issues in Molecular Biology (2024) Vol. 47, Iss. 1, pp. 8-8
Open Access | Times Cited: 4
Motor abilities and cognitive performance in Latinos with autosomal dominant Alzheimer's disease
Andrew J. Petkus, Anup N. Sonti, Lucy Montoya, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100010-100010
Open Access
The Research Progress of Drugs for Treatment of AlzheimerS Disease
Yuchen Zhang
Theoretical and Natural Science (2025) Vol. 68, Iss. 1, pp. 221-226
Open Access
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients
Chunsong Zhao, Taoran Li, Shuwen Hao, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Closed Access
Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease
Andrew J. Petkus, Anup N. Sonti, Lucy Montoya, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer’s Disease: A Narrative Review
Erica Spina, Riccardo Rocco Ferrari, Elisa Pellegrini, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 229-229
Open Access
Postbiotics as a Therapeutic Tool in Alzheimer's Disease: Insights into Molecular Pathways and Neuroprotective Effects
Garry Hunjan, Khadga Raj Aran
Ageing Research Reviews (2025), pp. 102685-102685
Closed Access
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meeting
Ronald C. Petersen, Ana Graf, Chris Brady, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access
Korean Red Ginseng Marc-Derived Gintonin Improves Alzheimer’s Cognitive Dysfunction by Upregulating LPAR1
Yunsok Ha, Rami Lee, Seung Ho Jeon, et al.
The American Journal of Chinese Medicine (2025), pp. 1-25
Closed Access
Korean Black Ginseng Extract Alleviates Alzheimer’s Disease-Related Cognitive Impairment by Activating the Nrf2/HO-1 Pathway and Suppressing the p38 MAPK/NF-κB/STAT3 Pathways and NLRP3 Inflammasome via TLR2 and TLR4 Modulation
Yujeong Ha, Hyo-Sung Jo, Tae Woo Kwon, et al.
Journal of Ginseng Research (2025)
Open Access
Machine learning to detect Alzheimer's disease with data on drugs and diagnoses
Johanna Wallensten, Caroline Wachtler, Nenad Bogdanović, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100115-100115
Open Access
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting system
Jingjing Huang, Xiaohong Long, Chunyong Chen
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Engineered nanoparticles for the treatment of Alzheimer’s disease
Jia Jia, Shuang Zhao, Jinghan Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lactobacilli Probiotics Prevent Amyloid-Beta Fibril Formation In Vitro
Sanaa Harass, Michael Quansah, Sachin Kumar, et al.
(2025)
Closed Access
Unraveling the Immune Puzzle: Role of Immunomodulation in Alzheimer’s Disease
Ashvin, Rishika Dhapola, Sneha Kumari, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top